Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Immunology|April 1, 1985
Recombinant interleukin 2 differentiates alloantigen-primed Lyt-2+ T cells into the activated cytotoxic stateR Yoshimoto, N Kashima, K Okada, et al.
Japanese Journal of Cancer Research : Gann|December 1, 1994
Synergistic antimetastatic effects of lentinan and interleukin 2 with pre- and post-operative treatmentsJ Hamuro, F Takatsuki, T Suga, et al.
Experimental Hematology|February 1, 1996
Improvement of erythroid toxicity by lentinan and erythropoietin in mice treated with chemotherapeutic agentsF Takatsuki, Y Miyasaka, T Kikuchi, et al.
Molecular Biology & Medicine|December 1, 1986
Production and characterization of the extracytoplasmic portion of the human interleukin-2 receptorA Shimizu, N Kondo, S Kondo, et al.
Journal of Surgical Oncology|August 1, 1987
Effects of serum immunosuppressive factors on antitumor cytotoxicity of interleukin 2-induced lymphocytesY Sugiyama, K Sakata, S Saji, et al.
Japanese Journal of Cancer Research : Gann|October 1, 1985
Decreased response to interleukin-2 of cancer patients in terms of augmentation of natural killer cell activityY Abe, S Ajitsu, J Hamuro, et al.
The Journal of Rheumatology|March 15, 2001
Abundant expression of common cytokine receptor gamma chain (CD132) in rheumatoid jointsJ Nishio, H Kohsaka, T Shimamura, et al.
Pageof 6